Personlig profil
Expertise
Haemato-oncologist. Responsible for treatment of malignant lymphoma and for experimental/phase I treatment of haematological malignancies at Rigshospitalet. Head of service for Hodgkin lymphoma, Mantle cell lymphoma and Castleman’s disease.
Primære forskningsområder
Hodgkin lymphoma; Mantle cell lymphoma; PET/CT in lymphoma; PET-response adapted lymphoma treatment; Phase 1 haematology studies;
Aktuel forskning
Chairman of the EORTC lymphoma group since 2013. Co-author of the international response criteria and guidelines for the use of imaging in lymphoma. Co-author of the European society of Medical Oncology (ESMO) guidelines for Hodgkin lymphoma and ’ultra high-risk’ lymphomas.
Faculty member for the EHA Clinical Research Training in Haematology programme
Member of the scientific committee for the European Haematology Association
National principal investigator or sub-investigator for >25 solid tumour and haematology phase I trials
National principal investigator for three mantle cell lymphoma trials (one ongoing and two planned) and three Hodgkin lymphoma trials.
Site principal investigator or sub-investigator for >20 lymphoma and myeloma phase II and phase III trials
Mulige interessekonflikter
None
Fingeraftryk
- 1 Lignende profiler
Samarbejde og topforskningsområder i de sidste fem år
-
Efficacy and safety of epcoritamab in relapsed or refractory large B-cell lymphoma: 3-year update from the EPCORE NHL-1 trial
Karimi, Y. H., Cheah, C. Y., Clausen, M. R., Cunningham, D., Farooq, U., Feldman, T., Ghesquieres, H., Jurczak, W., Linton, K. M., Phillips, T., Vose, J. M., Kim, W. S., Jafarinasabian, P., D'Angelo Månsson, B., Soong, D., Steele, A. J., Li, Z., Eskelund, C. W., Hutchings, M. & Thieblemont, C., 4 feb. 2026, I: Annals of Hematology. 105, 3, s. 79 79.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
-
An Individualized Prediction Model for Early-Stage Classic Hodgkin's Lymphoma
Rodday, A. M., Evens, A. M., Maurer, M. J., Upshaw, J. N., Counsell, N., Rossetti, S., Chang, C., Cui, Z., Xiang, Q., Mwangi, R., Advani, R., Andre, M., Gallamini, A., Hay, A. E., Hodgson, D. C., Hoppe, R. T., Hutchings, M., Johnson, P., Mou, E. & Opat, S. & 4 flere, , sep. 2025, I: NEJM Evidence. 4, 9, EVIDoa2500115.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
-
Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients
Bröckelmann, P. J., Böll, B., Molin, D., Schneider, G., Leppä, S., Meissner, J., Kamper, P., Hutchings, M., Christensen, J. H., Schnetzke, U., Fuchs, M., Jablonski, J., Eichenauer, D. A., von Tresckow, B., Klapper, W., Kobe, C., Borchmann, P. & Fosså, A., aug. 2025, I: HemaSphere. 9, 8, e70190.Publikation: Bidrag til tidsskrift › Letter › peer review
2 Citationer (Scopus) -
Changes in Lean Muscle Mass, Muscle Strength, and Physical Performance Following First-Line Chemotherapy in Patients With Lymphoma
Grønset, C. N., Jarden, M., Christensen, J., Simonsen, C., Tolver, A., Suetta, C. & Hutchings, M., nov. 2025, I: Hematological Oncology. 43, 6, e70154.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
1 Citationer (Scopus) -
Circulating Tumor DNA Determinants of Response and Outcome in Relapsed/Refractory Mantle Cell Lymphoma
Meriranta, L., Rask Kragh Jørgensen, R., Pasanen, A., Kolstad, A., Hutchings, M., Niemann, C. U., El Galaly, T. C., Riise, J., Christensen, J. H., Sonnevi, K., Pedersen, L. B., Wader, K. F., Glimelius, I., Leppä, S. & Jerkeman, M., 9 sep. 2025, I: Blood advances. 9, 17, s. 4528-4541 14 s.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
6 Citationer (Scopus)